Ebitda Zmiana Data
AbbVie USD 6.91B 3.22B 2026-06
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
ALKERMES USD 120.06M 19.15M 2026-09
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Cytokinetics USD -160.3M 9.02M 2026-06
Exelixis USD 275.36M 19.96M 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Pfizer USD 6.36B 350M 2026-09
Prothena USD -18.49M 44.46M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Repligen USD 43.84M 70K 2026-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Teva Pharmaceutical Industries USD 1.5B 1.02B 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09